Search Results - "Aldinc, Emre"

Musculoskeletal manifestations associated with transthyretin-mediated (ATTR) amyloidosis: a systematic review by Aldinc, Emre, Campbell, Courtney, Gustafsson, Finn, Beveridge, Abigail, Macey, Richard, Marr, Laura, Summers, Catherine, Zhang, Dafang

“…Abstract Background Hereditary and wild-type transthyretin-mediated (ATTRv and ATTRwt) amyloidoses result from the misfolding of transthyretin and aggregation…”
Get full text

Impact of baseline polyneuropathy severity on patisiran treatment outcomes in the APOLLO trial by Quan, Dianna, Obici, Laura, Berk, John L., Ando, Yukio, Aldinc, Emre, White, Matthew T., Adams, David

“…Assess how baseline polyneuropathy severity impacts response to patisiran regarding neurologic impairment and quality of life (QOL) in patients with hereditary…”
Get full text

Analysis of autonomic outcomes in APOLLO, a phase III trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis by González-Duarte, Alejandra, Berk, John L., Quan, Dianna, Mauermann, Michelle L., Schmidt, Hartmut H., Polydefkis, Michael, Waddington-Cruz, Márcia, Ueda, Mitsuharu, Conceição, Isabel M., Kristen, Arnt V., Coelho, Teresa, Cauquil, Cécile A., Tard, Céline, Merkel, Madeline, Aldinc, Emre, Chen, Jihong, Sweetser, Marianne T., Wang, Jing Jing, Adams, David

“…Hereditary transthyretin-mediated (hATTR) amyloidosis is a progressive, debilitating disease often resulting in early-onset, life-impacting autonomic…”
Get full text

Association of the transthyretin variant V122I with polyneuropathy among individuals of African ancestry by Parker, Margaret M., Damrauer, Scott M., Tcheandjieu, Catherine, Erbe, David, Aldinc, Emre, Hawkins, Philip N., Gillmore, Julian D., Hull, Leland E., Lynch, Julie A., Joseph, Jacob, Ticau, Simina, Flynn-Carroll, Alexander O., Deaton, Aimee M., Ward, Lucas D., Assimes, Themistocles L., Tsao, Philip S., Chang, Kyong-Mi, Rader, Daniel J., Fitzgerald, Kevin, Vaishnaw, Akshay K., Hinkle, Gregory, Nioi, Paul

“…Hereditary transthyretin-mediated (hATTR) amyloidosis is an underdiagnosed, progressively debilitating disease caused by mutations in the transthyretin ( TTR )…”
Get full text

Impact of Baseline Neuropathy Severity on Vutrisiran Treatment Response in the Phase 3 HELIOS-A Study by Luigetti, Marco, Quan, Dianna, Berk, John L., Conceição, Isabel, Misumi, Yohei, Chao, Chi-Chao, Bender, Shaun, Aldinc, Emre, Vest, John, Adams, David

“…Introduction Hereditary transthyretin (ATTRv, v for variant) amyloidosis is a rare, progressive, fatal disease with multisystem manifestations, caused by…”
Get full text

Correction to: Analysis of autonomic outcomes in APOLLO, a phase III trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis by González-Duarte, Alejandra, Berk, John L., Quan, Dianna, Mauermann, Michelle L., Schmidt, Hartmut H., Polydefkis, Michael, Waddington-Cruz, Márcia, Ueda, Mitsuharu, Conceição, Isabel M., Kristen, Arnt V., Coelho, Teresa, Cauquil, Cécile A., Tard, Céline, Merkel, Madeline, Aldinc, Emre, Chen, Jihong, Sweetser, Marianne T., Wang, Jing Jing, Adams, David

“…The original version of this article unfortunately contained a mistake…”
Get full text

Outpatient Worsening Heart Failure in Patients with Transthyretin Amyloidosis with Cardiomyopathy in the HELIOS-B Trial by Fontana, Marianna, Maurer, Mathew S., Gillmore, Julian D., Bender, Shaun, Aldinc, Emre, Eraly, Satish A., Jay, Patrick Y., Solomon, Scott D.

Get full text

Treatment response and neurofilament light chain levels with long-term patisiran in hereditary transthyretin-mediated amyloidosis with polyneuropathy: 24-month results of an open-label extension study by Ticau, Simina, Aldinc, Emre, Polydefkis, Michael, Adams, David, Coelho, Teresa, Ueda, Mitsuharu, Hale, Cecilia, Vest, John, Nioi, Paul

“…Longitudinal changes in neurofilament light chain (NfL) levels were evaluated alongside prespecified clinical assessments 24 months into the patisiran Global…”
Get full text

Neurofilament light chain as a biomarker for monitoring response to change in treatment in hereditary ATTR amyloidosis by Sato, Mitsuto, Mochizuki, Yusuke, Takahashi, Yusuke, Takasone, Ken, Aldinc, Emre, Ticau, Simina, Jia, Gang, Sekijima, Yoshiki

Get full text

Neurofilament Light Chain as a Biomarker of Hereditary Transthyretin-Mediated Amyloidosis by Ticau, Simina, Sridharan, Gautham V., Tsour, Shira, Cantley, William L., Chan, Amy, Gilbert, Jason A., Erbe, David, Aldinc, Emre, Reilly, Mary M., Adams, David, Polydefkis, Michael, Fitzgerald, Kevin, Vaishnaw, Akshay, Nioi, Paul

“…OBJECTIVETo identify changes in the proteome associated with onset and progression of ATTRv amyloidosis, we performed an observational, case-controlled study…”
Get full text

Impact of Baseline Polyneuropathy Severity on Vutrisiran Treatment Response in the Phase 3 HELIOS-A Study (P2-11.015) by Quan, Dianna, Luigetti, Marco, Berk, John, Conceição, Isabel, Misumi, Yohei, Chao, Chi-Chao, Bender, Shaun, Aldinc, Emre, Vest, John, Adams, David

“…Abstract only…”
Get full text

TUR-PSO: A cross-sectional, study investigating quality of life and treatment status of psoriasis patients in Turkey by Atakan, Nilgün, Yazici, Ayça Cordan, Özarmağan, Güzin, İnalÖz, Hüseyin Serhat, Gürer, Mehmet Ali, Sabuncu, İlham, Kİremİtçİ, Ümmühan, Alper, Sibel, Aytekİn, Sema, Arican, Özer, Polat, Mualla, Doğan, Sibel, Aldİnç, Emre

“…Psoriasis is a common inflammatory disease that has a severe impact on quality of life. There is lack of data regarding epidemiological and clinical features…”
Get full text

NfL Levels Significantly Decrease in Response to Treatment with Patisiran or Vutrisiran in hATTR Amyloidosis with Polyneuropathy (S14.001) by Polydefkis, Michael, Aldinc, Emre, Nienhuis, Hans, Karam, Chafic, Ajroud-Driss, Senda, Sekijima, Yoshiki, Waddington-Cruz, Marcia, Barnes, Jennifer, Nioi, Paul, Ticau, Simina

“…Abstract only…”
Get full text

Neurofilament Light Chain (NfL) as a Potential Biomarker of Treatment Response in Hereditary Transthyretin-Mediated Amyloidosis: Data from the Patisiran Global OLE Study (1291) by Polydefkis, Michael, Ticau, Simina, Erbe, David, McManus, Anastasia, Aldinc, Emre, Adams, David, Reilly, Mary M., Vaishnaw, Akshay, Nioi, Paul

“…Abstract only…”
Get full text

Neurofilament light chain as a biomarker for hereditary ATTR amyloidosis - correlation between neurofilament light chain and nerve conduction study by Tajiri, Masateru, Sato, Mitsuto, Kodaira, Minori, Matsushima, Akira, Mochizuki, Yusuke, Takahashi, Yusuke, Takasone, Ken, Aldinc, Emre, Ticau, Simina, Jia, Gang, Sekijima, Yoshiki

“…Neurofilament light chain (NfL) is a biomarker of neuronal injury in hereditary ATTR (ATTRv) amyloidosis. However, the correlation between NfL and nerve…”
Get full text

Transthyretin-stabilising mutation T119M is not associated with protection against vascular disease or death in the UK Biobank by Parker, Margaret M., Ticau, Simina, Butler, James, Erbe, David, Merkel, Madeline, Aldinc, Emre, Hinkle, Gregory, Nioi, Paul

“…Background: Destabilised transthyretin (TTR) can result in the progressive, fatal disease transthyretin-mediated (ATTR) amyloidosis. A stabilising TTR…”
Get full text

Neurofilament Light Chain may Serve As a Biomarker of Neuropathy in Hattr Amyloidosis with Cardiomyopathy by Ticau, Simina, Sridharan, Gautham, Tsour, Shira, Cantley, William, Chan, Amy, Gilbert, Jason A., Erbe, David, Vest, John, Fitzgerald, Kevin, Vaishnaw, Akshay, Aldinc, Emre, Nioi, Paul

“…Hereditary transthyretin-mediated (hATTR) amyloidosis is a progressive, life-threatening disease due to deposition of transthyretin (TTR) amyloid in various…”
Get full text

Perceptions of Painful Diabetic Peripheral Neuropathy in South-East Asia: Results from Patient and Physician Surveys by Malik, Rayaz A., Aldinc, Emre, Chan, Siew-Pheng, Deerochanawong, Chaicharn, Hwu, Chii-Min, Rosales, Raymond L., Yeung, Chun-Yip, Fujii, Koichi, Parsons, Bruce

“…There are no data on physician–patient communication in painful diabetic peripheral neuropathy (pDPN) in the Asia–Pacific region. The objective of this study…”
Get full text

The V122I Variant in Hereditary Transthyretin-Mediated Amyloidosis is Significantly Associated with Polyneuropathy by Parker, Margaret M., Damrauer, Scott M., Tcheandjieu, Catherine, Erbe, David, Aldinc, Emre, Hawkins, Philip N., Gillmore, Julian, Hull, Leland E., Lynch, Julie A., Joseph, Jacob, Ticau, Simina, Flynn-Carroll, Alexander O., Deaton, Aimee M., Ward, Lucas D., Assimes, Themistocles L., Tsao, Philip S., Chang, Kyong-Mi, Rader, Daniel J., Fitzgerald, Kevin, Vaishnaw, Akshay K., Hinkle, Gregory, Nioi, Paul

“…Hereditary transthyretin-mediated (hATTR) amyloidosis is a progressively debilitating disease caused by mutations in the transthyretin (TTR) gene. The V122I…”
Get full text

Efficacy and safety of etanercept in psoriasis and psoriatic arthritis in the PRESTA study: analysis in patients from Central and Eastern Europe by Damjanov, Nemanja, Karpati, Sarolta, Kemeny, Lajos, Bakos, Noemi, Bobic, Branislav, Majdan, Maria, Tlustochowicz, Witold, Vitek, Petr, Dokoupilova, Eva, Aldinc, Emre, Szumski, Annette

“…Background: Data are limited on the effectiveness of anti-TNF and other biologics on psoriatric arthritis (PsA) in Central and Eastern Europe (CEE). The…”
Get full text